UTMD实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Stats
今日成交量	54 158
平均成交量	20 083
市值	235.73M
EPS	$1.090 ( Q1 \| 2024-05-10 )
下一个收益日期	( $0 ) 2024-07-23
Last Dividend	$0.300 ( 2024-06-14 )
Next Dividend	$0 ( N/A )
P/E	14.85 (Sector) 42.63 (Industry) 0
ATR14	$0.183 (0.27%)

AKYA -4.10%

ANGO 2.02%

APR 0.00%

ATRC -2.23%

ATRI -0.16%

ATRS 0.18%

AVGR -3.13%

AZTA 1.00%

BLFS 4.54%

EKSO 0.48%

FEMY -0.87%

GMVD 1.38%

HBIO -1.72%

HOLX 0.05%

ICUI 0.03%

IIN 0.12%

ISRG -0.06%

KRMD -7.02%

LMAT 0.00%

LMNX 0.00%

MASI -4.23%

MBOT -0.97%

MHUA -2.27%

MMSI 3.01%

NEPH 0.96%

NSTG -37.43%

NVCR -2.84%

NXGL -0.69%

OSUR 0.95%

PDEX 3.92%

PLSE 1.63%

POAI 0.00%

QDEL -0.92%

RGEN -0.42%

SDC -53.45%

SMTI -2.99%

STAA 1.80%

STSS 0.21%

UTMD -0.06%

XRAY -0.88%

ZTEK 4.90%

Insider Trading

Date	Person	Action	Amount	type
2024-05-17	Richins Paul O	Sell	225	Common Stock
2023-10-27	Koopman Brian	Buy	500	Employee Stock Option - Right to Buy
2023-06-15	Koopman Brian	Sell	60	Common Stock
2023-05-18	Richins Paul O	Sell	700	Common Stock
2023-03-17	Richins Paul O	Sell	150	Common Stock

INSIDER POWER
-28.45
Last 100 transactions
Buy: 7 349 \| Sell: 108 167

相关性 (AI algo v.1.1b): Undervalued: 0.09% $66.85 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

Utah Medical Products Inc 相关性

10 最正相关
GOVX	0.96
BIOL	0.958
REVB	0.957
MRBK	0.955
KRNY	0.954
EXTR	0.952
CBNK	0.949
MNSB	0.947
INDB	0.944
PETS	0.944

10 最负相关
MSVB	-0.956
MOR	-0.942
BRAC	-0.934
VERA	-0.933
FLXS	-0.929
CRBP	-0.926
APXI	-0.92
META	-0.918
EZPW	-0.917
LPLA	-0.917

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Utah Medical Products Inc 财务报表

Annual	2023
营收:	$50.22M
毛利润:	$24.35M (48.47 %)
EPS:	$4.58

FY	2023
营收:	$50.22M
毛利润:	$24.35M (48.47 %)
EPS:	$4.58

FY	2022
营收:	$52.28M
毛利润:	$32.20M (61.58 %)
EPS:	$4.53

FY	2021
营收:	$49.05M
毛利润:	$30.92M (63.03 %)
EPS:	$4.15

Financial Reports:

No articles found.

Utah Medical Products Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.290 (N/A)	$0.295 (N/A)	$0.295 (N/A)	$0.295 (N/A)	$0.295 (N/A)	$0.300 (N/A)	$0.300 (N/A)	$0.300 (N/A)	$0 (N/A)	$0 (N/A)

Utah Medical Products Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.06 - Increase likely (41.17%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2004-06-14
Last Dividend	$0.300	2024-06-14
Next Dividend	$0	N/A
Payout Date	2024-07-05
Next Payout Date	N/A
# dividends	81	--
Total Paid Out	$22.40	--
Avg. Dividend % Per Year	1.33%	--
Score	5.71	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.06
Div. Directional Score	9.56	--

Next Divdend (Est)
(2024-09-30)

$0.301 Estimate 74.81 %

Dividend Stability

1.00 Excellent

Dividend Score

5.71

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2004	$0.450	1.75%
2005	$0.630	2.84%
2006	$0.780	2.55%
2007	$0.885	2.68%
2008	$0.905	3.06%
2009	$0.925	3.86%
2010	$1.665	5.63%
2011	$0.945	3.50%
2012	$0.965	3.53%
2013	$0.985	2.57%
2014	$1.005	1.94%
2015	$1.025	1.77%
2016	$1.045	1.78%
2017	$1.065	1.49%
2018	$1.085	1.37%
2019	$1.105	1.30%
2020	$1.125	1.05%
2021	$2.86	3.41%
2022	$1.165	1.20%
2023	$1.185	1.21%
2024	$0.600	0.72%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
14 Jun 2024	$0.300	07 May 2024	14 Jun 2024	05 Jul 2024
14 Mar 2024	$0.300	06 Feb 2024	15 Mar 2024	03 Apr 2024
14 Dec 2023	$0.300	31 Oct 2023	15 Dec 2023	03 Jan 2024
14 Sep 2023	$0.295	01 Aug 2023	15 Sep 2023	03 Oct 2023
15 Jun 2023	$0.295	09 May 2023	16 Jun 2023	06 Jul 2023
16 Mar 2023	$0.295	07 Feb 2023	17 Mar 2023	04 Apr 2023
15 Dec 2022	$0.295	01 Nov 2022	16 Dec 2022	04 Jan 2023
15 Sep 2022	$0.290	02 Aug 2022	16 Sep 2022	05 Oct 2022
16 Jun 2022	$0.290	10 May 2022	17 Jun 2022	06 Jul 2022
17 Mar 2022	$0.290	08 Feb 2022	18 Mar 2022	05 Apr 2022
14 Dec 2021	$2.00	02 Nov 2021	15 Dec 2021	29 Dec 2021
15 Sep 2021	$0.285	03 Aug 2021	16 Sep 2021	05 Oct 2021
14 Jun 2021	$0.285	11 May 2021	15 Jun 2021	06 Jul 2021
16 Mar 2021	$0.285	09 Feb 2021	17 Mar 2021	02 Apr 2021
14 Dec 2020	$0.285	03 Nov 2020	15 Dec 2020	05 Jan 2021
14 Sep 2020	$0.280	11 Aug 2020	15 Sep 2020	05 Oct 2020
16 Jun 2020	$0.280	07 May 2020	17 Jun 2020	03 Jul 2020
12 Mar 2020	$0.280	13 Feb 2020	13 Mar 2020	02 Apr 2020
12 Dec 2019	$0.280	05 Nov 2019	13 Dec 2019	03 Jan 2020
12 Sep 2019	$0.275	08 Aug 2019	13 Sep 2019	03 Oct 2019

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.334	1.500	3.32	4.98	[0 - 0.5]
returnOnAssetsTTM	0.121	1.200	5.97	7.16	[0 - 0.3]
returnOnEquityTTM	0.131	1.500	9.66	10.00	[0.1 - 1]
payoutRatioTTM	0.263	-1.000	7.37	-7.37	[0 - 1]
currentRatioTTM	19.57	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	52.07	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	17.14	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00210	-1.500	9.96	-10.00	[0 - 0.6]
interestCoverageTTM	9.20	1.000	7.71	7.71	[3 - 30]
operatingCashFlowPerShareTTM	5.70	2.00	8.10	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.53	2.00	7.23	10.00	[0 - 20]
debtEquityRatioTTM	0.00223	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.573	1.000	3.79	3.79	[0.2 - 0.8]
operatingProfitMarginTTM	0.331	1.000	5.39	5.39	[0.1 - 0.6]
cashFlowToDebtRatioTTM	72.43	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.362	0.800	-0.919	-0.735	[0.5 - 2]
Total Score				12.07

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.77	1.000	8.61	0	[1 - 100]
returnOnEquityTTM	0.131	2.50	9.78	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.53	2.00	8.16	10.00	[0 - 30]
dividendYielPercentageTTM	1.789	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.70	2.00	8.10	10.00	[0 - 30]
payoutRatioTTM	0.263	1.500	7.37	-7.37	[0 - 1]
pegRatioTTM	6.66	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.421	1.000	1.978	0	[0.1 - 0.5]
Total Score				7.06

Utah Medical Products Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Utah Medical Products Inc

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.